With over €150 million under management in two funds, Vesalius Biocapital Partners has been actively investing since 2007, primarily in European companies involved in therapeutics development, medical devices & diagnostics, and eHealth/mHealth. They have a track record of being the lead investor in most of their financing rounds and work closely with entrepreneurs, providing not only funding but also advice, introductions to other venture capital players and healthcare companies, assistance with hiring, and exit optimization. Their focus is on companies with proprietary technology, strong data, and a competitive edge, and they are willing to invest in both early-stage companies and corporate spin-offs with more mature assets.